FDA Recall Terminated

CDC, Influenza A/H5 Subtyping Kit, Model/Catalog Number: FluIVD03-11

Recall: Z-2220-2024 · Initiated April 26, 2024

Recall

Recall Number
Z-2220-2024
Event Number
94739
Firm
Centers For Disease Control and Prevention
FEI Number
1050190
Product Code
OZE
Status
Terminated
Root Cause
Under Investigation by firm
Initiated
April 26, 2024
Posted
June 27, 2024
Terminated
February 5, 2025
Address
1600 Clifton Rd Ne, Atlanta, GA, 30329-4018

Description

CDC, Influenza A/H5 Subtyping Kit, Model/Catalog Number: FluIVD03-11

Reason

The H5b component may fail to amplify, resulting in an inconclusive result.

Action

The CDC notified customers via letter on 04/26/2024. Customers were instructed to halt use of the H5b component when testing a specimen with the CDC Influenza A/H5 subtyping kit, lot 220307. Proceed with testing with the InfA, H5a, and RP targets and do not delay resulting. If a specimen is positive for InfA and H5a, that is considered a presumptive H5 positive and should be sent to CDC immediately. Please reach out to [email protected] for further shipping guidance. If a specimen is positive for InfA and negative for H5a and has not been tested with the Influenza A Subtyping kit, proceed to testing the specimen with the Influenza A Subtyping kit. If a specimen is negative for all viral targets but positive for RP, that specimen is considered negative for Influenza A, H5. Please reach out to [email protected] with any inconclusive results.

Distribution

US Nationwide distribution.

Quantity

191 units